Cystic Fibrosis-related Diabetes

patients with diagnosis of CFRD will undergo the gold standard treatment for the disease (insulin therapy)

therapeutic optimization

β-cell Function and Insulin Sensitivity in Patients With Cystic Fibrosis

Characterization of β-cell Function and Insulin Sensitivity in Pre-transplant Patients With Cystic Fibrosis

index of first phase insulin secretion, calculated using the Minimum Model applied to the OGTT in patients with CF and various degrees of glucose homeostasis

index of second phase insulin secretion, calculated using the Minimum Model applied to the OGTT in patients with CF and various degrees of glucose homeostasis

index of insulin sensitivity, calculated with the appropriate formula applied to the OGTT in patients with CF and various degrees of glucose homeostasis

difference between pre- and post-institution of an optimal glycemic control

n° episodes of exacerbation/year, n° of severe exacerbation (need of hospitalization)/year, and patient-reported outcomes (PROs) obtained from a specific validated questionnaire (CF-quality of life questionnaire, 9 quality of life domains: Physical Functioning, Vitality, Emotional state, Social limitations, Role Limitations/School Performance, Embarrassment, Body Image, Eating Disturbances, Treatment Constraints. 3 symptom scales: Respiratory, Digestive, Weight. 1 health perception scale: Health Status (present/evolution).Scores range from 0 to 100, with higher scores indicating better health)

sinusitis/آلبومین

β-cell Function and Insulin Sensitivity in Patients With Cystic Fibrosis

کاملترین پایگاه داده گیاهان دارویی با پشتیبانی علمی